Interferon- γ and infectious diseases: Lessons and prospects
- PMID: 38635718
- DOI: 10.1126/science.adl2016
Interferon- γ and infectious diseases: Lessons and prospects
Abstract
Infectious diseases continue to claim many lives. Prevention of morbidity and mortality from these diseases would benefit not just from new medicines and vaccines but also from a better understanding of what constitutes protective immunity. Among the major immune signals that mobilize host defense against infection is interferon-γ (IFN-γ), a protein secreted by lymphocytes. Forty years ago, IFN-γ was identified as a macrophage-activating factor, and, in recent years, there has been a resurgent interest in IFN-γ biology and its role in human defense. Here we assess the current understanding of IFN-γ, revisit its designation as an "interferon," and weigh its prospects as a therapeutic against globally pervasive microbial pathogens.
Similar articles
-
Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.J Infect Dis. 2002 May 15;185(10):1490-501. doi: 10.1086/340221. Epub 2002 Apr 19. J Infect Dis. 2002. PMID: 11992286 Review.
-
Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases.Biomol Concepts. 2018 May 30;9(1):64-79. doi: 10.1515/bmc-2018-0007. Biomol Concepts. 2018. PMID: 29856726 Review.
-
Interferon-gamma, the activated macrophage, and host defense against microbial challenge.Ann Intern Med. 1988 Apr;108(4):595-608. doi: 10.7326/0003-4819-108-4-595. Ann Intern Med. 1988. PMID: 3126690 Review.
-
Clinical implications of interferon-γ genetic and epigenetic variants.Immunology. 2014 Dec;143(4):499-511. doi: 10.1111/imm.12362. Immunology. 2014. PMID: 25052001 Free PMC article. Review.
-
IFN-γ Priming Effects on the Maintenance of Effector Memory CD4(+) T Cells and on Phagocyte Function: Evidences from Infectious Diseases.J Immunol Res. 2015;2015:202816. doi: 10.1155/2015/202816. Epub 2015 Oct 5. J Immunol Res. 2015. PMID: 26509177 Free PMC article. Review.
Cited by
-
Inducible antibacterial responses in macrophages.Nat Rev Immunol. 2024 Sep 18. doi: 10.1038/s41577-024-01080-y. Online ahead of print. Nat Rev Immunol. 2024. PMID: 39294278 Review.
-
The Shigella flexneri effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylation.bioRxiv [Preprint]. 2024 Sep 5:2024.09.05.611450. doi: 10.1101/2024.09.05.611450. bioRxiv. 2024. PMID: 39282383 Free PMC article. Preprint.
-
Transcriptional control of interferon-stimulated genes.J Biol Chem. 2024 Sep 12;300(10):107771. doi: 10.1016/j.jbc.2024.107771. Online ahead of print. J Biol Chem. 2024. PMID: 39276937 Free PMC article. Review.
-
The emerging roles of UFMylation in the modulation of immune responses.Clin Transl Med. 2024 Sep;14(9):e70019. doi: 10.1002/ctm2.70019. Clin Transl Med. 2024. PMID: 39259506 Free PMC article. Review.
-
Tuberculosis in otherwise healthy adults with inherited TNF deficiency.Nature. 2024 Sep;633(8029):417-425. doi: 10.1038/s41586-024-07866-3. Epub 2024 Aug 28. Nature. 2024. PMID: 39198650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical